chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Low grade Fever (not taken with a thermometer).  Had a cough productive of small amount of sputum
Hives on neck and upper body  Itching on upper body Elevated Blood pressure and pulse Dizziness  Swelling at injection site within 10 mins after injection
Subsequently post vax, the pt developed an injection site reaction characterized by erythema, swelling, and itching. The pt recovered.
24MAY95 mom called approx 730PM talked w/D.O. N. Offers red streak fr inj site leg; saw MD 25MAY95 dx mild cellulitis given ATB x 5 days; also noted t102 & fussiness;
rash on face, back, shoulders, and stomach (dry, red, peeling skin--not itchy) extreme burning and stinging of urethra and vestibular tissues prickling of external vulvar tissues (labia majora and minora, perineum) swelling and redness of mans pubis and labia majora burning and stinging when urinating and deficating excoriated vulvar and vestibular tissues white, nonodorous vaginal discharge that comes back negative for every infection and virus
This spontaneous report was received from a medical assistant concerning a patient of unknown age and gender. On 20-AUG-2013, the patient was vaccinated with 0.5 milliliter (ml) of PNEUMOVAX23 (lot number and expiry date reported as H021941 and 11-JUL-2014 respectively), intramuscularly. No concomitant therapy was reported. On 21-AUG-2013, the patient came back into the office to report the adverse event. Approximately on an unknown date in August 2013, the patient experienced a large raised rash near the bottom of the muscle, near the elbow which was very painful after receiving the PNEUMOVAX23. The patient sought an unspecified medical attention. It was unspecified if any treatment was provided or if any lab tests were performed. The patient was not recovered from the events. The medical assistant was requesting a lot check for the PNEUMOVAX23. The relatedness for the events was unknown for PNEUMOVAX23. This is one of the two reports from the same source. Additional information has been requested.
Body aches; Chills; Fever; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Body aches), CHILLS (Chills) and PYREXIA (Fever) in a 37-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 046a21a) for COVID-19 vaccination.     No medical history was provided by the reporter. .  Concomitant products included OXCARBAZEPINE (OXTELLAR XR), ZONISAMIDE and CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for an unknown indication.   On 25-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 26-Mar-2021, the patient experienced MYALGIA (Body aches), CHILLS (Chills) and PYREXIA (Fever). The patient was treated with IBUPROFEN at an unspecified dose and frequency. At the time of the report, MYALGIA (Body aches), CHILLS (Chills) and PYREXIA (Fever) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 26-Mar-2021, Body temperature: 100.7 (High) Unknown.         Action taken with mRNA-1273 in response to the events was  not applicable.  For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.
This spontaneous report was received from a social media user, as part of a marketing research program and refers to an unspecified number of male patients of unknown age. There was no information about the patient's concurrent conditions, concomitant therapies or medical histories provided. On unknown dates, the patients were vaccinated with GARDASIL injection (exact dose, dose number, route of administration, anatomical location, lot # and expiration date were not reported). On unknown dates, the patients experienced impotence. The outcome of the event was unknown. The reporter considered the event to be related to GARDASIL. This is one of several reports received from the same reporter. Additional information has been requested.
2:AM on Feb 18 started chills while sleeping.   Had hot tea and blankets and it subsided.  fever of 100-101 throughout the day.  Sleeping. Pain at injection site . Symptoms lasted about a day and a half. This was the first dose!
Patient has intense pain, redness, and swelling at injection site. Heat and anti-inflammatory help with pain. Patient is not seeking additional medical treatment at this time.
This spontaneous report as received from a registered nurse refers to an unspecified number of unspecified patient (age and gender not reported). Information regarding patients drug reactions or allergies and medical history was not reported. On an unknown date unspecified number of unspecified patients were all administered PROQUAD (Merck) (dose, route of administration, anatomical location, lot#, expiration date were not reported) that underwent post supported excursion. Concomitant therapies were not reported. No adverse effects were reported by any patients. Product quality complaint (PQC) was not involved. This is one of several reports received from the same reporter. Additional information has been requested.
Shot on Tues. evening-nothing unusual. Wed am area slightly outlined in red-Wed pm while bathing noticed arm red, swollen, hard from shoulder to elbow-hurts and itches-gave MOTRIN-intents to give BENADRYL. He may have had a similar reaction last year-not sure which kid. Will call PCP on Fri if no better.
15 hours after receiving vaccine I has chills, fever, body aches, headache, fatigue.  This lasted about 48 hours, with lessening severity as time went on.  About 24 hours after vaccine pain, swelling, and hot to the touch, began at the vaccine sight.  This for permitted for about 7 days with lessening severity as time passed.  (I reported daily to V-safe, so that is a more accurate account of actual symptoms and timeline as this is being reported more than a month after receiving vaccine.)  No medical treatment was sought or required.
Itchy; body rash; This is a spontaneous report from a contactable consumer. A 67-years-old non pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for Injection, Batch/Lot number: EN6201) via an unspecified route of administration, in left arm on 12Feb2021 at 13:30 as dose number unknown, single for covid-19 immunisation. The patient medical history was not reported. patient was allergic to meclomen, phenergan, promethazine, nickel. The patient's concomitant medications included ibuprofen. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. On 13Feb2021 at 01:00 PM the patient experienced itchy body rash. No treatment was received. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the event was not resolved.  Follow-up (31May2021): Follow-up attempts completed. No further information expected.
pt recvd vax;T 101 R;17nov in the eve T 102 R;to MD;T down w/ apap;glands at neck,swollen;no rash;mom advised to cont apap;
After the 3rd does of the Pfizer COVID vaccine and a required annual influenza vaccine received in mid-October 2021, I began to develop myalgias and arthralgias much the same as I had during the time when I had active lupus - 30+ years prior.  I was quite ill for the first week after the influenza vaccine and also developed a disabling left shoulder and arm injury where the vaccine was injected.  My rheumatologist and I believe all of the vaccines received last year contributed to overactivity of my immune system leading to a reactivation of an auto-immune disorder (lupus) for the first time in decades.   An ANA in the spring of 2022 was positive for the first time in decades also.
COVID 19 Treatment; COVID 19 Treatment; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 55-year-old female patient (not pregnant) received bnt162b2 (BNT162B2), as dose 2, single (Batch/Lot number: unknown), in left arm for covid-19 immunisation; covid-19 vaccine (COVID-19 VACCINE), as dose 1, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID 19 Treatment". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Positive; Negative. Therapeutic measures were taken as a result of drug ineffective, covid-19. The information on the batch/lot number for bnt162b2 has been requested and will be submitted if and when received.
Rash accompanied by itching.  First appeared in groin area on 10/24/08.  Applied topical ointment.  Began to subside after 4-5 days.  Resurfaced in navel and both ankles on 10/30/08.  Applied topical ointment.  Began to subside after 4-5 days.  Resurfaced on both forearms, upper arms, underarms, scrotum and anus on 11/6/08.  Visited family physician and dermatologist on 11/7/08 and 11/10/08 respectively.  Unable to readily determine cause.  Continued applying topical ointment.  Rash showed little signs of improvement and resurfaced on left ankle.  Returned to dermatologist on 11/14/08.  Took biopsy from left arm (results pending).  Administered Prednisone 20 mg. for 8 days.  Treatment not yet completed.
1. cold 8-6-2012 2. Rash on buttocks first 8-12 3. rash on legs 8/16 4. lower leg biopsy 8/29. Diagnosis HSP (Henoch Scholein Purpura)  5. stomach and joint pain came and went. 6. Following are notes from company nurse. "Employee called to advise that he is being treated for HSP.  States that he received Typhim on 7/24, two weeks later got a cold (Aug. 5 or 6), was traveling and on 8/13 got rash on legs.  Advises that he had original rash on buttocks (unsure of date).  Was taking Malarone on 8/13 and advised to stop.  States that last week Aug 27, saw PCP and was on Z Pak and biopsy done of leg rash, Tuesday saw Dermatologist and Wed (8/29) saw Allergist who diagnosed HSP.  States that he is having joint pain now.  Had bloodwork completed on Renal Functions which he states were normal."
Patient complained about fever over 101 for 24 hours diarrhea (watery for more than 3 days). Aches for more than 72 hours took 3 days for pt to get back to normal.
Two children were given too much but it's not clear what the dosage was; This spontaneous case was reported by a consumer and describes the occurrence of ACCIDENTAL OVERDOSE (Two children were given too much but it's not clear what the dosage was) in a  patient of an unknown age and gender who received mRNA-1273 (Spikevax) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On an unknown date, the patient experienced ACCIDENTAL OVERDOSE (Two children were given too much but it's not clear what the dosage was). At the time of the report, ACCIDENTAL OVERDOSE (Two children were given too much but it's not clear what the dosage was) outcome was unknown.            No concomitant product reported by reporter. No treatment medication reported by reporter. Reporter was unclear whether it was Spikevax or another manufacturer's vaccine.   Reporter did not allow further contact
Vaccinated Arm is swollen, itchy  and dark red from the shoulder to the wrist
not getting her 2nd dose of SHINGRIX; This non-serious case was reported by a nurse via sales rep and described the occurrence of incomplete course of vaccination in a adult female patient who received Herpes zoster (Shingrix) for prophylaxis.   Previously administered products included Shingrix (received 1st dose on an unknown date).   On an unknown date, the patient did not receive the 2nd dose of Shingrix. On an unknown date, an unknown time after receiving Shingrix, the patient experienced incomplete course of vaccination (Verbatim: not getting her 2nd dose of SHINGRIX). The outcome of the incomplete course of vaccination was unknown.   Additional Information: GSK receipt date: 19-Jul-2023 The reporter was a field representative that was at a work related lunch gathering.   The reporter stated at lunch a nurse practitioner reported that she was not getting her 2nd dose of Shngrix due to an adverse event that another nurse practitioner, that works in her practice, experienced.   No further information available at this time. The reporter consented to follow up. The case was linked with case US2023099652, reported by the same reporter for different patient. Till the time of reporting, the patient did not receive the 2nd dose of Shingrix, which led to incomplete course of vaccination.; Sender's Comments:  US-GSK-US2023099652:same reporter, different patient
This spontaneous report as received from a pharmacist via company representative, refers to an unspecified number of patients of unknown age and gender. On an unknown dates, the patient were vaccinated with ZOSTAVAX subcutaneously (dose and lot# were not reported). On an unknown dates, the patient developed redness at the injection site after an unspecified amount of time. Cold compress and BENADRYL were given for the treatment. The outcome of the event was reported as recovered/resolved (dates unknown). The relatedness between the event ZOSTAVAX was not provided. Additional information has been requested.
Today his blood sugar is elevated; This spontaneous case was reported by a patient and describes the occurrence of BLOOD GLUCOSE INCREASED (Today his blood sugar is elevated) in a 76-year-old male patient who received mRNA-1273.815 (SPIKEVAX 2023-2024) for COVID-19 prophylaxis.    Co-suspect product included non-company product RSV VACCINE for an unknown indication.    Patient received other vaccines in the 4 weeks prior to COVID-19 vaccine.  Previously administered products included for Product used for unknown indication: COVID-19 vaccines (Dose 1), COVID-19 vaccines (Dose 4), COVID-19 vaccines (Dose 3) and COVID-19 vaccines (Dose 2). Past adverse reactions to the above products included No adverse event with COVID-19 vaccines, COVID-19 vaccines, COVID-19 vaccines and COVID-19 vaccines. Concurrent medical conditions included Type 2 diabetes mellitus.   On 13-Nov-2023, the patient received fifth dose of mRNA-1273.815 (SPIKEVAX 2023-2024) (unknown route) 1 dosage form and dose of RSV VACCINE (unknown route) 1 dosage form. On 17-Nov-2023, the patient experienced BLOOD GLUCOSE INCREASED (Today his blood sugar is elevated). At the time of the report, BLOOD GLUCOSE INCREASED (Today his blood sugar is elevated) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 17-Nov-2023, Blood glucose increased: increased.         No concomitant medication was reported. No treatment information was provided.
pt recvd vax;4 1/2 hrs p/ vax 3x nl size swollen arm;shoulder elbow;no redness,very tender;could not use arm;warm moist compresses used 6oct94, moset swelling gone; dizziness 6oct94;cold;shaking;severe acheness;better except dizzy 11oct94;
7 X 12 cm erythema, induration on rt thigh surrounding injection site; slightly tender but walking, running, climbing w/o problems.
A report has been received from a Health Professional concerning a 46 year old, female subject, who had been receiving FLUMIST. FLUMIST started on 25-Oct-2013. The patient experienced body aches in chest and ribs which started on 26-Oct-2013. At this time of reporting, the event of body aches in chest and ribs was ongoing. The report was considered to be non-serious by the reporter.
Pt had flu vaccine at pharmacy. 20 mins after vaccine pt developed urticaria all over arms and chest no SOB. Came to UC for treatment. Has had flu shot in past. W/O reaction. Pt respond to steroid and antihistamine.
Significant decrease in ability to function physically and mentally.  Increased confusion.  Unsteadiness resulting in two falls.  Weakness of muscles.  Facial numbness which lasted for several hours.  These symptoms showed up within a few days of the second dose of the Moderna vaccine.  The effects lasted for about one month.  Since then, the person is back to normal functioning with no weakness, or confusion.  She is doing well now but for one month following the Moderna vaccine was very debilitated and unable to function in normal activities of daily living.
Arm sore, burning (other family mbrs that got it were OK) stiffness in AM, (quarter-size redness) pt called 10/27: very hard to touch; area feels warm.
12:30PM - dizziness in cheeks 1:30PM - dizziness moves to top of his head 5PM - dizziness changes to pain, took 2 Tylenol 8PM - started to throw up, lost balance due to numbness on left side of his body    - tried to sleep it off as he thought he was just exhausted and a side effect of the shot NEXT DAY 7AM - called ambulance had a "Stroke Ischemic"
Information has been received from a registered nurse concerning a 15 year old female patient who on 12-JAN-2009 was vaccinated with the first dose of GARDASIL. On 13-MAR-2009 the patient was vaccinated with the second dose of GARDASIL. On 17-AUG-2009 the patient was vaccinated with the third dose of GARDASIL into her left deltoid. The patient developed ongoing arm pain after her third vaccination. The arm hurts when moved in specified ways. The patient sought medical attention in an office. At the time of the report, the patient's status was unknown. The health care professional contacted during telephone follow-up could not supply the following information: patient name, lot number, recovery status. This is one of several reports received from the same source. Additional information has been requested.
COVID-19; COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 37-year-old female patient (not pregnant) received BNT162b2 (BNT162B2), on 14Oct2021 as dose number unknown, single (Batch/Lot number: unknown) at the age of 37 years for covid-19 immunisation. The patient's relevant medical history included: "Asthma" (unspecified if ongoing). The patient does not have any known allergies. Concomitant medication(s) included: ZYRTEC ALLERGY; MONTELUKAST. The following information was reported: DRUG INEFFECTIVE (medically significant), COVID-19 (medically significant), outcome "unknown" and all described as "COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: Unknown results. Therapeutic measures were taken as a result of drug ineffective, covid-19.  The information on the batch/lot number for BNT162b2 has been requested and will be submitted if and when received.
On day 8 after my vaccine, I developed a rash around the injection site that is about 3 inches in diameter. It is very itchy, red, and hot to the touch. It has me anxious to receive the second shot because it happened so long after the vaccination.
got sick; Initial information received on 29-Dec-2021 regarding an unsolicited valid Social Media non-serious case received from a consumer/non-healthcare professional.  This case involves an unknown age and unknown gender patient who got sick while receiving vaccine INFLUENZA VACCINE.  The patient's past medical history, medical treatment(s), vaccination(s) and family history were not provided.    On an unknown date, the patient received a dose of suspect INFLUENZA VACCINE produced by unknown manufacturer (form, strength, dose, frequency, route, lot number, expiry date unknown) in unknown administration site as prophylactic vaccination (flu vaccine).  On an unknown date the patient developed a non-serious event "got sick" (illness) (unknown latency) following the administration of INFLUENZA VACCINE.  Action taken with INFLUENZA VACCINE (INFLUENZA VACCINE) was not applicable.  It was not reported if the patient received a corrective treatment for the event (got sick).  At time of reporting, the outcome was Unknown for the event got sick.
contracted COVID-19; contracted COVID-19; This is a spontaneous report received from contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the parent.  A 5-year-old female patient received BNT162b2 (BNT162B2), on 29Nov2021 as dose 1, single (Lot number: FK5127, Expiration Date: 03Dec2021), on 17Dec2021 as dose 2, single (Lot number: FK5127, Expiration Date: 21Jan2022) and on 23May2022 as dose 3 (booster), single (Lot number: FL0007) at the age of 5 years for covid-19 immunisation. The patient had no relevant medical history. No family medical history. There were no concomitant medications. No additional Vaccines Administered on Same Date, no prior vaccinations within 4 weeks. The following information was reported: VACCINATION FAILURE (medically significant), COVID-19 (medically significant) all with onset 03Jul2022, outcome "unknown" and all described as "contracted COVID-19". The patient underwent the following laboratory tests and procedures: SARS-CoV-2 test: (05Jul2022) Positive, notes: Vaccinated still tested positive for Covid-19 afterwards. tested positive on 05Jul2022; (unspecified date) Positive. Additional information: the reporter (patient's mother) reported that patient had 3 doses of the vaccine designed to lessen severe illness from a COVID-19 infection. Patient contracted COVID-19, likely 03Jul2022. Reporter's family all got vaccinated and still tested positive for covid19 afterwards on 05Jul2022.; Sender's Comments: Linked Report(s) : US-PFIZER INC-PV202200021017 Same reporter/vaccine/event, different patient.;
Upper and lower extremity numbness and tingling 5 days after Pfizer 3rd COVID vaccine which woke patient from sleep and has been waxing and waning over the past 4 days.
The morning after my vaccination I did have some symptoms come up. I woke up in the middle of the night very cold, with body aches, I felt miserable in general and under the weather. I did have fatigue afterwards for about 24 hours then I felt much better. In September I started feeling a tightness throughout my chest and I could feel my heart fluttering. After about 30 minutes after I called my daughter and we went to the ER that evening. My heart was racing up to about 180 BPM. My normal resting is around 65.  They placed me on a medication while I was staying over night however my heart settled down for about half an hour and then came right back up. It took all night for my heart to get back to a normal level. I was then sent home the next day and I have not had the occurrence since.
10 days after receiving the influenza vaccine, patient seen in emergency department for bilateral lower limb numbness that was ascending in nature over the course of 4 days. She had also started to experience hand numbness as well. Only minimal effects on walking and very little weakness noted. Patient subsequently diagnosed with AIDP/Guillian Barre syndrome by neurologist and required IVIG therapy. Thus far, patient is improving after initiation of IVIG treatment.